000 01365 a2200337 4500
005 20250515124215.0
264 0 _c20080812
008 200808s 0 0 eng d
022 _a1747-597X
024 7 _a10.1186/1747-597X-3-17
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDucharme, Lori J
245 0 0 _aState policy influence on the early diffusion of buprenorphine in community treatment programs.
_h[electronic resource]
260 _bSubstance abuse treatment, prevention, and policy
_cJun 2008
300 _a17 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aBuprenorphine
_xadministration & dosage
650 0 4 _aCommunity Health Services
_xorganization & administration
650 0 4 _aDiffusion of Innovation
650 0 4 _aFormularies as Topic
650 0 4 _aHealth Policy
650 0 4 _aHumans
650 0 4 _aMedicaid
_xorganization & administration
650 0 4 _aNarcotic Antagonists
_xadministration & dosage
650 0 4 _aOpioid-Related Disorders
_xdrug therapy
650 0 4 _aState Government
650 0 4 _aUnited States
700 1 _aAbraham, Amanda J
773 0 _tSubstance abuse treatment, prevention, and policy
_gvol. 3
_gp. 17
856 4 0 _uhttps://doi.org/10.1186/1747-597X-3-17
_zAvailable from publisher's website
999 _c18054841
_d18054841